Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Regulatory vaccination campaign

India HPV Campaign Crosses 80 Lakh Doses

Analysis based on 27 articles · First reported Sep 11, 2026 · Last updated Sep 11, 2026

Sentiment
5
Attention
2
Articles
27
Market Impact
General
Live prominence charts, article sentiment distribution, and event development timeline available on the Ergen Dashboard

The milestone is a public-health achievement that modestly supports demand for HPV vaccine makers such as Merck & Co., whose Gardasil-4 is used in the campaign, though the free government procurement limits near-term revenue upside. Broader market impact is minimal, as the event is a domestic healthcare program update rather than a major economic or corporate development.

pharmaceuticals healthcare

India has crossed 80 lakh (8 million) Human Papillomavirus (HPV) vaccine doses administered under the National HPV Vaccination Campaign, the Bangladesh — Ministry of Health and Family Welfare said on Friday. The campaign was launched by Prime Minister Narendra Modi on February 28, 2026, to provide free, voluntary, single-dose Gardasil-4 HPV vaccination to 14-year-old girls at government health facilities, with parental consent. The vaccine prevents cervical cancer, the second most common cancer among women in India. According to Registrar General of India 2021 estimates, approximately 1.2 crore girls form the annual cohort of 14-year-olds eligible to benefit each year. India — Uttar Pradesh leads with over 22 lakh adolescent girls vaccinated. India — Gujarat, India — Madhya Pradesh, India — Mizoram and India — Uttar Pradesh have achieved 100 percent coverage of their identified target populations; India — Bihar, India — Andhra Pradesh and India — Assam have crossed 90 percent; India — Karnataka has achieved over 85 percent; and India — Chhattisgarh, India — Sikkim, India — Kerala, India — Telangana and India — Odisha have crossed 60 percent. Vaccination sessions are supervised by trained medical officers, with sites linked to 24x7 adverse events following immunisation management centres. The U-WIN digital platform tracks coverage and identifies gaps. Health workers including ASHAs and ANMs, teachers, and experts from institutions such as All India Institutes of Medical Sciences supported mobilisation. The World Health Organization reports cervical cancer caused around 604,000 new cases and 280,000 deaths globally in 2024. India reports over 120,000 new cases and nearly 80,000 fatalities annually. The campaign is entering its final phase, with focus on reaching remaining eligible beneficiaries.

80 India launch vaccination program
60 India — Uttar Pradesh vaccinated over 22 lakh
50 Narendra Modi launched vaccination campaign
50 India — Gujarat achieved 100 percent coverage
50 India — Madhya Pradesh achieved 100 percent coverage
50 India — Mizoram achieved 100 percent coverage
40 India — Bihar crossed 90 percent coverage
40 India — Andhra Pradesh crossed 90 percent coverage
40 India — Assam crossed 90 percent coverage
35 India — Karnataka achieved over 85 percent coverage
30 India — Chhattisgarh crossed 60 percent coverage
30 India — Sikkim crossed 60 percent coverage
30 India — Kerala crossed 60 percent coverage
30 India — Telangana crossed 60 percent coverage
+ 1 more actions View on Dashboard
cnt
India is the implementing nation of the campaign and the milestone strengthens its preventive healthcare profile.
Importance 95.0 Sentiment 10.0
govactor
The ministry announced the milestone and oversees the campaign rollout across states and union territories.
Importance 90.0 Sentiment 5.0
loc
India — Uttar Pradesh leads with over 22 lakh vaccinations and 100 percent coverage of its target cohort.
Importance 70.0 Sentiment 5.0
per
The Prime Minister launched the National HPV Vaccination Campaign on February 28, 2026.
Importance 60.0 Sentiment 5.0
loc
India — Gujarat achieved 100 percent coverage of its identified target population.
Importance 55.0 Sentiment 5.0
loc
India — Madhya Pradesh achieved 100 percent coverage of its identified target population.
Importance 55.0 Sentiment 5.0
loc
India — Mizoram achieved 100 percent coverage of its identified target population.
Importance 50.0 Sentiment 5.0
loc
India — Bihar crossed 90 percent coverage of its target cohort.
Importance 45.0 Sentiment 5.0
loc
India — Andhra Pradesh crossed 90 percent coverage, with 98.47 percent reported.
Importance 45.0 Sentiment 5.0
loc
India — Assam crossed 90 percent coverage, aided by integrated community health networks.
Importance 45.0 Sentiment 5.0
loc
India — Karnataka achieved more than 85 percent coverage of its target cohort.
Importance 40.0 Sentiment 5.0
stock
Merck manufactures Gardasil-4, the single-dose vaccine used free of cost in the campaign, supporting volume demand though at government procurement terms.
Importance 40.0 Sentiment 5.0
loc
India — Chhattisgarh crossed 60 percent coverage of its target cohort.
Importance 35.0 Sentiment 5.0
loc
India — Sikkim crossed 60 percent coverage of its target cohort.
Importance 35.0 Sentiment 5.0
loc
India — Kerala crossed 60 percent coverage of its target cohort.
Importance 35.0 Sentiment 5.0
+ 5 more entities View on Dashboard
ERGEN INTELLIGENCE
Track this event live

Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.